As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal
In Brief: Coalition Begins Campaign To Educate Public
About Need For Cancer Research Funding
NCI Okays Agreement Between Allegheny, Pitt, Over NSABP
NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group
Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says
OSI Underestimated Magnitude Of Gallo Case: Hadley
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









